[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20085031L - Benzimidazolmodulatorer av VR1 - Google Patents

Benzimidazolmodulatorer av VR1

Info

Publication number
NO20085031L
NO20085031L NO20085031A NO20085031A NO20085031L NO 20085031 L NO20085031 L NO 20085031L NO 20085031 A NO20085031 A NO 20085031A NO 20085031 A NO20085031 A NO 20085031A NO 20085031 L NO20085031 L NO 20085031L
Authority
NO
Norway
Prior art keywords
benzimidazole
modulators
benzimidazole modulators
compounds
formula
Prior art date
Application number
NO20085031A
Other languages
English (en)
Other versions
NO341965B1 (no
Inventor
Wenxi Pan
Scott L Dax
Raul L Calvo
Mark R Player
William H Parsons
Michael Brandt
Sharmila Patel
Jian Liu
Wing S Cheung
Michele C Jetter
Yu-Kai Lee
Mark A Youngman
Kenneth M Wells
Derek A Beauchamp
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20085031L publication Critical patent/NO20085031L/no
Publication of NO341965B1 publication Critical patent/NO341965B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Oppfinnelsen angår forbindelser med formelen (I):. til farmasøytiske sammensetninger som inneholder slike forbindelser og fremgangsmåter for behandling ved anvendelse av dem.
NO20085031A 2006-05-03 2008-12-02 Benzimidazolmodulatorer av VR1 NO341965B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79750406P 2006-05-03 2006-05-03
PCT/US2007/066748 WO2007130780A2 (en) 2006-05-03 2007-04-17 Benzimidazole modulators of vr1

Publications (2)

Publication Number Publication Date
NO20085031L true NO20085031L (no) 2009-01-06
NO341965B1 NO341965B1 (no) 2018-03-05

Family

ID=38566108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085031A NO341965B1 (no) 2006-05-03 2008-12-02 Benzimidazolmodulatorer av VR1

Country Status (37)

Country Link
US (3) US7951829B2 (no)
EP (1) EP2021330B1 (no)
JP (1) JP5302884B2 (no)
KR (1) KR101434883B1 (no)
CN (1) CN101511797B (no)
AR (1) AR060840A1 (no)
AT (1) ATE482201T1 (no)
AU (1) AU2007248341C1 (no)
BR (1) BRPI0709803B8 (no)
CA (1) CA2651128C (no)
CO (1) CO6160329A2 (no)
CR (1) CR10479A (no)
CY (1) CY1111269T1 (no)
DE (1) DE602007009378D1 (no)
DK (1) DK2021330T3 (no)
EA (1) EA019386B1 (no)
EC (1) ECSP088854A (no)
ES (1) ES2350959T3 (no)
HK (1) HK1131971A1 (no)
HR (1) HRP20100700T1 (no)
IL (1) IL194916A (no)
JO (1) JO3602B1 (no)
MX (1) MX2008014108A (no)
MY (1) MY154595A (no)
NI (1) NI200800290A (no)
NO (1) NO341965B1 (no)
NZ (1) NZ572251A (no)
PE (1) PE20080065A1 (no)
PL (1) PL2021330T3 (no)
PT (1) PT2021330E (no)
RS (1) RS51473B (no)
SI (1) SI2021330T1 (no)
TW (1) TWI419882B (no)
UA (1) UA94749C2 (no)
UY (1) UY30322A1 (no)
WO (1) WO2007130780A2 (no)
ZA (1) ZA200810234B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0721169A2 (pt) * 2006-12-15 2014-03-18 Janssen Pharmaceutica Nv Inibidores de benzimidazol trpv1
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
PE20091102A1 (es) 2007-12-17 2009-07-25 Janssen Pharmaceutica Nv Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1
US20090156598A1 (en) * 2007-12-17 2009-06-18 Lebsack Alec D Imidazolopyrimidine modulators of TRPV1
US8362012B2 (en) * 2008-04-18 2013-01-29 Daewoong Pharmaceutical Co., Ltd. Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
US8232409B2 (en) 2008-10-15 2012-07-31 Janssen Pharmaceutica N.V. Heterocyclic benzimidazoles as TRPM8 modulators
US8217060B2 (en) * 2009-05-15 2012-07-10 Janssen Pharmaceutica, Nv Benzimidazole derivatives useful as TRP M8 receptor modulators
US8323805B2 (en) * 2009-06-04 2012-12-04 Nitto Denko Corporation Emissive aryl-heteroaryl acetylenes
CN102002010A (zh) * 2009-08-31 2011-04-06 住友化学株式会社 双噁唑啉基烷烃化合物的精制方法
MX2013013330A (es) 2011-05-16 2014-07-09 Cellceutix Corp Compuestos para utilizar en el tratamiento de mucositis.
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
EP2970269B1 (en) 2013-03-14 2017-04-19 Novartis AG 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
EP3019488B1 (en) 2013-07-11 2018-11-07 Bristol-Myers Squibb Company Ido inhibitors
JP2016535042A (ja) 2013-10-30 2016-11-10 ノバルティス アーゲー ２−ベンジル−ベンゾイミダゾール補体因子ｂ阻害剤およびその使用
EP3348554B1 (en) * 2015-09-08 2020-05-06 Sumitomo Chemical Company, Limited Method for producing triazole compound
JP7041141B2 (ja) * 2016-11-01 2022-03-23 メルク・シャープ・アンド・ドーム・コーポレーション 置換された二環式ヘテロアリール系ニコチン性アセチルコリン受容体アロステリック調節剤
KR102709804B1 (ko) * 2018-05-03 2024-09-25 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 레티노이드-관련 희귀 수용체 감마(ＲＯＲγ)의 조절제로서 벤즈이미다졸 유도체 및 이의 약학적 용도
CN108997398B (zh) * 2018-07-23 2020-12-15 被忽略疾病药物研发组织 一种3,3-二甲基苯并[c][1,2]氧杂戊硼烷-1(3h)-醇的制备方法
CN112745268B (zh) * 2019-10-31 2022-09-16 江苏恒瑞医药股份有限公司 苯并咪唑衍生物的晶型及制备方法
MX2022005260A (es) * 2019-10-31 2022-06-09 Jiangsu Hengrui Medicine Co Sal de adicion acida de regulador rorgamma.
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063169A1 (en) * 2003-01-13 2004-07-29 Astellas Pharma Inc. Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US6299796B1 (en) 1997-12-18 2001-10-09 Fuji Photo Film Co., Ltd. Styryl compound, method for the preparation thereof and electroluminescent element employing the same
US6748803B1 (en) * 2000-02-22 2004-06-15 Simmonds Precison Products, Inc. Liquid measurement system and shared interface apparatus for use therein
EP1551811A1 (en) * 2002-10-17 2005-07-13 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
DK1660491T3 (da) * 2003-07-28 2008-11-10 Janssen Pharmaceutica Nv Benzimidazol-, benzthiazol- og benzoxazolderivater og deres anvendelse som LTA4Hmodulatorer
RU2006118312A (ru) * 2003-10-28 2007-12-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Бензимидазолы, полезные в качестве модуляторов ионных каналов
WO2006058338A2 (en) * 2004-11-29 2006-06-01 Janssen Pharmaceutica N.V. 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor
PL2081572T3 (pl) * 2006-07-04 2010-07-30 Janssen Pharmaceutica Nv Benzimidazolowe związki antagonistyczne wobec receptora kannabinoidowego zawierające podstawioną grupę heterocykliczną
BRPI0721169A2 (pt) * 2006-12-15 2014-03-18 Janssen Pharmaceutica Nv Inibidores de benzimidazol trpv1

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004063169A1 (en) * 2003-01-13 2004-07-29 Astellas Pharma Inc. Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RAMI H K ET AL, "The therapeutic potential of TRPV1 (VR1) antagonists: clinical answers await", DRUG DISCOVERY TODAY: THERAPEUTIC STRATEGIES, ELSEVIER, (200409), vol. 1, no. 1, ISSN 1740-6773, pages 97 - 104, Dated: 01.01.0001 *
WALPOLE C S J ET AL, "THE DISCOVERY OF CAPSAZEPINE, THE FIRST COMPETITIVE ANTOGONIST OF THE SENSORY NEURON EXCITANTS CAPSAICIN AND RESINIFERATOXIN", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19940624), vol. 37, no. 13, ISSN 0022-2623, pages 1942 - 1954, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
EA019386B1 (ru) 2014-03-31
EA200870497A1 (ru) 2009-06-30
RS51473B (en) 2011-04-30
KR101434883B1 (ko) 2014-08-27
SI2021330T1 (sl) 2011-01-31
AU2007248341B2 (en) 2011-12-08
JP5302884B2 (ja) 2013-10-02
PL2021330T3 (pl) 2011-03-31
EP2021330B1 (en) 2010-09-22
US7951829B2 (en) 2011-05-31
AU2007248341C1 (en) 2013-01-17
MX2008014108A (es) 2008-11-14
CN101511797A (zh) 2009-08-19
CR10479A (es) 2009-03-31
DE602007009378D1 (de) 2010-11-04
BRPI0709803B8 (pt) 2021-05-25
ES2350959T3 (es) 2011-01-28
TWI419882B (zh) 2013-12-21
CN101511797B (zh) 2013-01-02
NO341965B1 (no) 2018-03-05
PT2021330E (pt) 2010-12-03
US20110190364A1 (en) 2011-08-04
JO3602B1 (ar) 2020-07-05
ATE482201T1 (de) 2010-10-15
JP2009535414A (ja) 2009-10-01
ZA200810234B (en) 2010-02-24
NZ572251A (en) 2010-08-27
ECSP088854A (es) 2008-11-27
CO6160329A2 (es) 2010-05-20
TW200808738A (en) 2008-02-16
IL194916A0 (en) 2009-08-03
BRPI0709803B1 (pt) 2019-12-10
NI200800290A (es) 2012-01-30
HRP20100700T1 (hr) 2011-02-28
WO2007130780A3 (en) 2008-02-14
BRPI0709803A2 (pt) 2011-07-26
AR060840A1 (es) 2008-07-16
HK1131971A1 (en) 2010-02-12
IL194916A (en) 2013-01-31
PE20080065A1 (es) 2008-02-25
US20110190344A1 (en) 2011-08-04
KR20090008428A (ko) 2009-01-21
US20070259936A1 (en) 2007-11-08
AU2007248341A1 (en) 2007-11-15
CA2651128A1 (en) 2007-11-15
EP2021330A2 (en) 2009-02-11
UA94749C2 (en) 2011-06-10
CA2651128C (en) 2014-09-02
CY1111269T1 (el) 2015-08-05
UY30322A1 (es) 2007-08-31
WO2007130780A2 (en) 2007-11-15
MY154595A (en) 2015-06-30
DK2021330T3 (da) 2010-12-06

Similar Documents

Publication Publication Date Title
NO20085031L (no) Benzimidazolmodulatorer av VR1
NO20093009L (no) Kondensert ring heterocykel kinase modulatorer
EA200970156A1 (ru) Пиридизиноновые производные
NO20083057L (no) Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20090596L (no) Antivirale fosfinatforbindelser
MX2008000017A (es) Derivados de isoquinolina como inhibidores de rho-cinasa.
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
NO20092569L (no) Inhibitorer av Akt-aktivitet
NO20083220L (no) Heterocykliske derivater som modulatorer for ionekanaler
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
GT200600327A (es) Ciclohexilaminoisoquinolona
NO20091083L (no) Organiske forbindelser
NO20090783L (no) Pyrimidonforbindelser som inhibitorer av GSK-3
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
EA201170772A1 (ru) Органические соединения
MA32508B1 (fr) Composes organiques
NO20080150L (no) Inhibitorer av AKT-aktivitet
NO20090295L (no) Substituerte heteroarylderivater
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
NO20065678L (no) 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer.
NO20081160L (no) Benzimidazoltiofen forbindelser
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
NO341679B1 (no) Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren